$NVAX $24 Dec 9, 2024

NVAX Novavax stock, $24 on 12/9/24. ctv.veeva.com/study/phase-3-study-of-the-safety-and-immunogenicity-of-covid-19-and-influenza-combination-vaccine Phase 3 trial begins on Monday, Dec. 9, 2024. Squeezing.